pioglitazone has been researched along with Myositis, Inclusion Body in 1 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Myositis, Inclusion Body: Progressive myopathies characterized by the presence of inclusion bodies on muscle biopsy. Sporadic and hereditary forms have been described. The sporadic form is an acquired, adult-onset inflammatory vacuolar myopathy affecting proximal and distal muscles. Familial forms usually begin in childhood and lack inflammatory changes. Both forms feature intracytoplasmic and intranuclear inclusions in muscle tissue. (Adams et al., Principles of Neurology, 6th ed, pp1409-10)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The sporadic form of inclusion body myositis (IBM) is the most common late-onset myopathy." | 2.61 | Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras. ( De Paepe, B, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Paepe, B | 1 |
1 review available for pioglitazone and Myositis, Inclusion Body
| Article | Year |
|---|---|
Sporadic Inclusion Body Myositis: An Acquired Mitochondrial Disease with Extras.
Topics: Biomarkers; Cytokines; DNA, Mitochondrial; Growth Differentiation Factor 15; Humans; Hypoglycemic Ag | 2019 |